New patent for Optnose Us drug XHANCE

Annual Drug Patent Expirations for XHANCE Xhance is a drug marketed by Optnose Us and is included in one NDA. It is available from one supplier. The generic ingredient in… The post New patent for Optnose Us drug XHANCE appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: